A case of non-Hodgkin's lymphoma and invasive thymoma treated with R-CHOP therapy

被引：4
|
作者：
Yamato, Hiroaki
Tsutsumi, Yutaka
Ehira, Nobuyuki
Kanamori, Hiroe
Shimoyama, Norihiko
Tanaka, Junji
Imamura, Masahiro
Asaka, Masahiro
Hasegawa, Tadashi
Masauzi, Nobuo
机构：
[1] Hakodate Municipal Hosp, Dept Internal Med, Hakodate, Hokkaido 0418680, Japan
[2] Hakodate Municipal Hosp, Dept Clin Pathol, Hakodate, Hokkaido 0418680, Japan
[3] Hakodate Municipal Hosp, Dept Cardiovasc Surg, Hakodate, Hokkaido 0418680, Japan
[4] Hokkaido Univ, Grad Sch Med, Dept Hematol & Oncol, Sapporo, Hokkaido, Japan
[5] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol, Sapporo, Hokkaido, Japan
来源：
INTERNATIONAL JOURNAL OF HEMATOLOGY | 2006年 / 83卷 / 05期
关键词：
D O I：
10.1532/IJH97.05192
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：464 / 466
页数：3
相关论文
共 50 条
  • [31] Therapy of non-Hodgkin's lymphoma
    J. Coffey
    D. C. Hodgson
    M. K. Gospodarowicz
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : S28 - S36
  • [32] UNRECOGNIZED RENAL INSUFFICIENCY AMONG NON-HODGKIN LYMPHOMA PATIENTS TREATED WITH R-CHOP: EVALUATION OF PREVALENCE, CHARACTERISTICS AND EFFECT ON REGIMEN RELATED TOXICITY
    Leader, A.
    Kaptzon, S.
    Maor, M.
    Itchaki, G.
    Cohen, O.
    Vidal, L.
    Gvili, A. Gafter
    Joffe, E.
    Lishner, M.
    HAEMATOLOGICA, 2015, 100 : 659 - 660
  • [33] Side effects of CHOP in the treatment of non-Hodgkin's lymphoma
    Sitzia, J
    North, C
    Stanley, J
    Winterberg, N
    CANCER NURSING, 1997, 20 (06) : 430 - 439
  • [34] Preclinical results of SGN-CD19A in combination with R-ICE or R-CHOP in non-Hodgkin lymphoma models
    Van Epps, Heather A.
    Klussman, Kerry
    Anderson, Martha
    Zeng, Weiping
    Olson, Devra
    Ryan, Maureen
    Albertson, Tina
    Law, Che-Leung
    CANCER RESEARCH, 2015, 75
  • [35] High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP
    Dhar, Sukanya
    Chakravarti, Mohona
    Ganguly, Nilanjan
    Saha, Akata
    Dasgupta, Shayani
    Bera, Saurav
    Sarkar, Anirban
    Roy, Kamalika
    Das, Juhina
    Bhuniya, Avishek
    Ghosh, Sarbari
    Sarkar, Madhurima
    Hajra, Srabanti
    Banerjee, Saptak
    Pal, Chiranjib
    Saha, Bhaskar
    Mukherjee, Kalyan Kusum
    Baral, Rathindranath
    Bose, Anamika
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [36] Dose-escalation of CHOP in non-Hodgkin's lymphoma
    Santoro, A
    Balzarotti, M
    Tondini, C
    Zanini, M
    Giardini, R
    Latteri, F
    Rampinelli, I
    Bufalino, R
    ANNALS OF ONCOLOGY, 1999, 10 (05) : 519 - 525
  • [37] Reduced-dose CHOP therapy for elderly patients with non-Hodgkin's lymphoma
    Mori, M
    Niitsu, N
    Takagi, T
    Tomiyama, J
    Matsue, T
    Nakagawa, Y
    Okamoto, R
    LEUKEMIA & LYMPHOMA, 2001, 41 (3-4) : 359 - 366
  • [38] Weight and body composition changes during R-CHOP chemotherapy in patients with non-Hodgkin's lymphoma and their impact on dose intensity and toxicity
    Stanisavljevic, N. S.
    Marisavljevic, D. Z.
    JOURNAL OF BUON, 2010, 15 (02): : 290 - 296
  • [39] R-CHOP therapy for MALT lymphoma of the rectum
    Chihara, Dai
    Kagami, Yoshitoyo
    Oki, Yasuhiro
    Kato, Harumi
    Onoda, Hiroshi
    Ine, Shouji
    Taji, Hirofumi
    Yamamoto, Kazuhito
    Morishima, Yasuo
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (01) : 84 - 86
  • [40] Is R-CHOP Therapy a Lymphoma Growth Factor?
    Farnault, Laure
    Mercier, Cedric
    Berda-Haddad, Yael
    Sebahoun, Gerard
    Costello, Regis
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (01) : E295 - E297
12345